Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Neurology"
DOI: 10.1007/s00415-019-09272-6
Abstract: BackgroundNo postmarketing randomised clinical trials are available about alemtuzumab, and real-world data are limited. We aimed to analyse the efficacy and safety of alemtuzumab in a single-centre cohort of patients with relapsing–remitting MS.MethodsPatients who took… read more here.
Keywords: alemtuzumab real; efficacy safety; cohort patients; safety alemtuzumab ... See more keywords